Madrona Venture Group, LLC
In its 13F for Q4 2025 (holdings as of December 31, 2025, filed February 13, 2026), Madrona Venture Group, LLC reported 3 stock positions worth $22.1 million. Its top holding was Nautilus Biotechnology (NAUT) at 53.2% of the portfolio, followed by Uipath Class A (PATH, 45.2%) and Ginkgo Bioworks (DNA, 1.6%). Its holdings were unchanged from Q3 2025.
- Most Recent 13F
- Q4 2025
- Location
- SEATTLE, WA
- CIK
- 0001887785
- Portfolio Value
- $22.1M (Q4 2025)
- SEC Filing
- 0001887785-26-000001 ↗ filed Feb 13, 2026
Holdings Value
Holdings 3 stocks · $22.1M
Portfolio Sells Q3 2025 → Q4 2025
| None this quarter. | |||
Portfolio Buys Q3 2025 → Q4 2025
| None this quarter. | |||
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q4 2025 | 3 | $22.1M | NAUT, PATH, DNA |
| Q3 2025 | 3 | $13.8M | PATH, NAUT, DNA |
| Q2 2025 | 3 | $12.6M | PATH, NAUT, DNA |
| Q1 2025 | 3 | $28.5M | SNOW, PATH, NAUT |
| Q4 2024 | 4 | $53.8M | SNOW, NAUT, PATH, BCOV |
| Q3 2024 | 4 | $74.6M | SNOW, NAUT, PATH, BCOV |
| Q2 2024 | 4 | $93.7M | SNOW, NAUT, PATH, BCOV |
| Q1 2024 | 4 | $117.5M | SNOW, NAUT, PATH, BCOV |